Vigilant Biosciences
PrivateLast Round
VC Round
Nov 1, 2019
Est. Valuation
$7.8M
Total Funding Raised
$13.02M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vigilant Biosciences operates in Healthcare & Life Sciences and is based in Lakeway, Texas. Its latest recorded funding round was a VC Round in November 2019.
Vigilant Biosciences is a healthcare company that develops and provides solutions for the early detection of oral and oropharyngeal cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vigilant Biosciences Comparables
Compare Vigilant Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CURO Biosciences Private Limited | 82% | |
| Forward Science | 82% | |
| OrisDX | 79% |
For institutional investors. Book with your work email.
Vigilant Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2019 | ||||
| Grant | Aug 11, 2016 | ||||
| Series B Extension | Jul 11, 2016 | ||||
| Series B | Feb 24, 2015 | ||||
| Series A | Mar 25, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vigilant Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institute for Commercialization of Florida Technology | Series B |
| venVelo | Series B, Series B Extension |
| National Institute of Dental and Craniofacial Research | Grant |
| Novalis LifeSciences | VC Round |
| White Owl Capital Partners | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 187% MoM.
- May 12, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
Vigilant Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vigilant Biosciences's valuation, stock price, and market status.
Is Vigilant Biosciences a public or private company?
Vigilant Biosciences is a private company.
What is the current stock price of Vigilant Biosciences?
Vigilant Biosciences is a private company, so its shares have no public market price. Caplight tracks Vigilant Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vigilant Biosciences worth (valuation)?
Vigilant Biosciences's valuation is estimated at $7.8M based on funding round data.
Can I buy Vigilant Biosciences stock?
Vigilant Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vigilant Biosciences's last funding round?
Vigilant Biosciences's most recent funding round was VC Round on November 1, 2019.
Who are the main investors in Vigilant Biosciences?
Key investors in Vigilant Biosciences include Novalis LifeSciences.
Will Vigilant Biosciences IPO soon?
No public IPO plans have been announced for Vigilant Biosciences.
How can I track Vigilant Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Vigilant Biosciences's shares on secondary markets.